Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMulberry Group Regulatory News (MUL)

Share Price Information for Mulberry Group (MUL)

Share Price is delayed by 15 minutes
Get Live Data
131.50    4.00 (3.14%)
Bid:
128.00
Ask:
135.00
Spread: 7.00 (5.469%)
Market Cap: £92.26m
MUL Live PriceLast checked at - London Stock Exchange

Intraday Mulberry Group Share Chart

Trading Update

14 Oct 2014 07:00

RNS Number : 1828U
Mulberry Group PLC
14 October 2014
Β 

ο»Ώ

MULBERRY GROUP PLC ("Mulberry" or the "Group")

TRADING UPDATE

Β 

Mulberry Group plc, the English luxury brand, is updating the market on trading for the six months ended 30 September 2014 and the outlook for the remainder of the current financial year ending 31 March 2015.

Β 

As reported on 12 June 2014, the company anticipated a challenging year. The first half was expected to be particularly difficult, with it taking some time for the measures implemented after the April management change to take effect. Actual trading conditions have been more difficult than expected, in part due to the continuing headwinds affecting the luxury sector. Whilst sales trends have improved as the period progressed, indicating that the right steps are being taken to restore the business to growth, H1 revenues were down 17% to Β£64.7 million (2013: Β£78.1 million) and profit before tax for the full year to March 2015 is expected to be significantly below current expectations.

Β 

Retail

Β 

The Retail business fell by 9% to Β£45.1 million (2013: Β£49.5 million), with a decline in the UK offset by growth in International markets:

Β· UK full price sales were down Β£2.7 million (-12%) to Β£20.9 million. Sales have been adversely affected by a decline in footfall, particularly tourist shoppers;

Β· UK outlet sales have continued to normalise from unusually high levels during the prior year, when discontinued inventories were being cleared. Outlet sales were down Β£3.0 million (-23%) to Β£10.1 million;

Β· International Retail sales were up Β£1.2 million (+20%) to Β£7.5 million;

Β· Online sales were up Β£0.1 million (+1%) to Β£6.6 million, accounting for 10% of Group sales (2013: 8%).

Β 

Wholesale

Β 

Wholesale sales declined during H1 by Β£9.0 million (-31%) to Β£19.6 million. This decline, which has been greater than anticipated, reflects a combination of inventory reduction and conservative ordering by our Asian and European franchise partners.

Β 

OUTLOOK

Β 

Following the launch of the Tessie bag family during June, we introduced a new family of bags developed with Cara Delevingne at the beginning of September. The reaction to these bag families has been positive and they have contributed to the improving sales trends. The next new product arrives in-store during November 2014 in time for Christmas, with the launch of the new Blossom tote bag, the Mini Lily and a new collection of small leather goods.

Β 

We expect the wholesale sales pattern to continue for the remainder of this year before improving during 2015/16 as partner store sales stabilise and their inventories reduce.

Β 

We maintain tight cost control across the business, albeit with a large proportion of costs remaining fixed. The opening of the Paris flagship store, planned for late Spring 2015, will mark the end of a period of accelerated investment in new stores establishing the foundations for the next phase of growth in both Europe and North America. This investment has involved significant capital investment and increased the fixed costs of the business substantially. Looking forward, the focus will be on growing sales to generate a return on this investment.

Β 

We remain confident that we are taking the right steps to restore the business to growth. As we have explained, we expect that the improvement will be progressive over the medium term.

Β 

GODFREY DAVIS, EXECUTIVE CHAIRMAN, COMMENTED:

"As I explained in June, my first actions on returning as acting chief executive focused upon reinforcing our product ranges. I explained that the impact would be progressive and should produce benefits over the medium term. The new products are beginning to reach our shops with the launch of the Cara Delevingne bags at the beginning of September and with further new product being offered in our shops during November. As expected, the first half has been difficult, but the Group remains profitable and cash generative, giving us the resources to invest for the future. Despite the current challenges, I remain confident that we will build on Mulberry's solid foundations and unique brand positioning in the luxury market to restore growth in the medium term."

Β 

Β 

H1 2014/15

Retail Like-for-like sales

Retail Total sales

10 weeks to

16 weeks to

26 weeks to

26 weeks to

This year vs. last year (%)

07-Jun-14

30-Sep-14

30-Sep-14

30-Sep-14

UK full price

-12%

-13%

-12%

-12%

UK outlet

-24%

-26%

-25%

-23%

UK retail total*

-17%

-17%

-17%

-16%

International retail total*

-8%

2%

-2%

20%

Online total

-7%

3%

1%

1%

Group retail total**

-15%

-12%

-13%

-9%

*regional splits exclude online sales

**Retail total LFL sales for the 10 weeks to 7-Jun-14 were previously reported

Β 

Β 

The interim results announcement for the six months ended 30 September 2014 is scheduled to be released on 4 December 2014.

Β 

Β 

FOR FURTHER DETAILS PLEASE CONTACT:

Β 

Bell Pottinger

Daniel de Belder / Joanna Boon

07977 927142 / 020 3772 2499

Mulberry Investor Relations

Allegra Perry

020 7605 6795

Altium

Ben Thorne / Katie Hobbs

020 7484Β 4040

Barclays

Marcus Jackson / Nicola Tennent

Β 

020 3134 8370

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTQKNDDFBDDBKD
Date   Source Headline
25th Jan 201712:02 pmRNSPrice Monitoring Extension
8th Dec 20167:00 amRNSHalf Year Report
8th Dec 20167:00 amRNSNew Business Agreement in North Asia
6th Sep 201611:58 amRNSResult of AGM
1st Aug 20167:30 amRNSChange of name of Nominated Adviser
4th Jul 201611:12 amRNSHolding(s) in Company
1st Jul 201612:34 pmRNSGrants under 2008 Unapproved Share Option Scheme
16th Jun 20167:00 amRNSPreliminary Results
16th May 20162:00 pmRNSDirectorate Change
7th Mar 20167:00 amRNSAPPOINTMENT OF GROUP FINANCE DIRECTOR
16th Dec 20151:06 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSHalf Yearly Report
21st Sep 20151:13 pmRNSDirector's Dealing
18th Sep 20157:00 amRNSDirector's Dealing
14th Sep 20157:00 amRNSDirector's Dealing
11th Sep 201511:16 amRNSHolding(s) in Company
8th Sep 201511:38 amRNSResult of AGM
3rd Sep 20153:35 pmRNSDirectorate Change
13th Jul 20153:27 pmRNSGrants under 2008 Unapproved Share Option Scheme
9th Jul 20157:00 amRNSDirector's Dealing
11th Jun 20157:00 amRNSPreliminary Results
10th Apr 20153:42 pmRNSGrant under 2008 Unapproved Share Option Scheme
9th Apr 20157:00 amRNSTrading Update
12th Mar 20157:00 amRNSTHIERRY ANDRETTA APPOINTED AS CHIEF EXECUTIVE
22nd Dec 20144:35 pmRNSPrice Monitoring Extension
12th Dec 20142:59 pmRNSGrants under 2008 Unapproved Share Option Scheme
4th Dec 20147:00 amRNSHalf Yearly Report
2nd Dec 20147:00 amRNSBoard Appointment
1st Dec 20144:29 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSAppointment of new Creative Director
14th Oct 20147:00 amRNSTrading Update
13th Oct 201410:48 amRNSHolding(s) in Company
16th Sep 20144:42 pmRNSDirector Announcement
8th Sep 201411:52 amRNSResult of AGM
5th Aug 20148:52 amRNSHolding(s) in Company
31st Jul 20142:03 pmRNSDirector/PDMR Shareholding
2nd Jul 20144:00 pmRNSDirector's Dealing
18th Jun 20144:34 pmRNSDirector's Dealing
12th Jun 20147:00 amRNSPreliminary Results
10th Jun 20147:00 amRNSBoard Appointment
6th Jun 20144:35 pmRNSPrice Monitoring Extension
27th May 201411:00 amRNSNotice of Results
24th Apr 201411:03 amRNSHolding(s) in Company
17th Apr 20147:00 amRNSTrading Update
20th Mar 20147:00 amRNSBoard Changes
6th Feb 201412:57 pmRNSHolding(s) in Company
3rd Feb 20141:51 pmRNSHolding(s) in Company
29th Jan 20147:00 amRNSTrading Update
31st Dec 201310:00 amRNSTotal Voting Rights
11th Dec 20133:15 pmRNSDirector Dealing and Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.